Barbados vs Portugal: Cause of death, by non-communicable diseases, female
Barbados
81.1%
in 2021
Portugal
81.5%
in 2021
Barbados rank
31st
Portugal rank
30th
Cause of death, by non-communicable diseases, female over time
- Barbados
- Portugal
How they compare
Portugal currently reports 81.5% against 81.1% in Barbados, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Portugal ahead.
Barbados ranks 31st and Portugal ranks 30th of 185 countries.
Across the 3 decades both report, Barbados averaged higher in 2 and Portugal in 1.
Head to head by decade
| Decade | Barbados | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.7% | 89.9% | 3.2% | Portugal |
| 2010s | 88.7% | 87.9% | 0.8% | Barbados |
| 2020s | 85.3% | 82.0% | 3.4% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Barbados or Portugal?
- Portugal, at 81.5% against 81.1% in Barbados as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Barbados and Portugal?
- 0.4%, with Portugal ahead.
- How many years of comparable data are there for Barbados and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Barbados and Portugal rank globally for cause of death, by non-communicable diseases, female?
- Barbados ranks 31st and Portugal ranks 30th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.